Statement of Use

PTO- 1553

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1553

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:
MARK: FUJISIL(Standard Characters, see http://uspto.report/TM/88141655/mark.png)
SERIAL NUMBER: 88141655
An Extension of Time form is being filed with the Allegation of Use.


OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Fuji Chemical Industries Co., Ltd., having an address of
      55 Yokohoonji, Kamiichi-machi
      Nakaniikawa-gun
      Toyama Prefecture, 9300397
      Japan
      Email: XXXX
Proposed: Fuji Chemical Industries Co., Ltd., having an address of
      55 Yokohoonji, Kamiichi-machi
      Nakaniikawa-gun
      Toyama Prefecture, 9300397
      Japan
      Phone:
      Email: XXXX

The owner is submitting the following allegation of use information:

For International Class 001:
Current identification: Chemicals, namely, chemicals for use in industry; chemical additives for use in the manufacture of pharmaceuticals; silicon dioxide powder; chemicals made of silicon dioxide; Chemicals, namely, chemicals for use in industry made of silicon dioxide; chemical additives for use in the manufacture of dietary supplements for humans; excipients for use in the development, formulation and manufacture of pharmaceuticals, pharmaceutical intermediaries, drug formulations, veterinary and nutritional products

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 10/00/2019, and first used in commerce at least as early as 10/00/2019, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) Label on package containing the goods and close up of label.

JPG file(s):
Specimen File1
Original PDF file:
SPN0-104129196126-2021042 7205745911643_._FUJISIL_C l_1_Product_Label_close_u p.pdf
Converted PDF file(s) (1 page)
Specimen File1

Webpage URL: None Provided
Webpage Date of Access: None Provided

For International Class 003:
Current identification: Chemicals, namely chemicals sold as components of cosmetics

All ITU goods/services in this class are to be deleted


For International Class 005:
Current identification: Pharmaceutical preparations, namely, pharmaceutical preparations for use in dermatology, and for use in the manufacture of solid dosage drugs; dietary supplements for humans; additives for dietary supplements for humans; fodder additives for medical purposes, namely, dietary supplement for animals and humans; dietary supplement for animals; chemicals, namely, chemical preparations for sanitary use

All ITU goods/services in this class are to be deleted


The applicant is not filing a Request to Divide with this Allegation of Use form. Correspondence Information (current):
      David Davis
      PRIMARY EMAIL FOR CORRESPONDENCE: chiusptomail@bakermckenzie.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): david.davis@bakermckenzie.com; shima.roy@bakermckenzie.com; meri.mclaughlin@bakermckenzie.com

The docket/reference number is 180994.
Correspondence Information (proposed):
      David Davis
      PRIMARY EMAIL FOR CORRESPONDENCE: chiusptomail@bakermckenzie.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): david.davis@bakermckenzie.com; shima.roy@bakermckenzie.com; meri.mclaughlin@bakermckenzie.com

The docket/reference number is 180994.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.


Declaration



Original PDF file:
hw_104129196126-205745911 _._FUJISIL_-_SOU_form.pdf
Converted PDF file(s) (1 page)
Signature File1

Signatory's Name: Hiroyoshi Kinpara
Signatory's Position: General Manager of Intellectual Property Department
Signature method: Handwritten

PAYMENT: 88141655
PAYMENT DATE: 04/28/2021

Serial Number: 88141655
Internet Transmission Date: Wed Apr 28 16:54:31 ET 2021
TEAS Stamp: USPTO/SOU-XXX.XXX.XXX.XXX-20210428165431
766649-88141655-780eb8be56db2353afaacbdb
b69d9d4b9e7caf8b185cd83e837e3eef16563ca3
363-DA-54294125-20210428165204858606